文献速递胃肠外科

腹腔镜远端胃切除术联合D2淋巴结清扫与开腹手术治疗局部进展期胃癌的多中心随机对照试验短期结果

Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT).
PubMed 文献 · Ann Surg · 2019-01-01

KLASS-02-RCT多中心随机对照试验比较腹腔镜远端胃切除术(LDG)联合D2淋巴结清扫与开腹远端胃切除术(ODG)治疗局部进展期胃癌的短期结局。共随机分配1050例cT2-4a、N0-1期胃腺癌患者,实际分析1011例。LDG组早期并发症发生率显著低于ODG组(16.6% vs 24.1%,P=0.003),术后镇痛药使用和疼痛评分更低,排气更早(3.5 vs 3.7天,P=0.025),术后住院更短(8.1 vs 9.3天,P=0.005),90天死亡率两组相似(0.4% vs 0.6%,P=0.682)。

要点

  • LDG联合D2清扫治疗局部进展期胃癌的早期并发症发生率显著低于ODG(16.6% vs 24.1%,P=0.003)。
  • LDG组术后疼痛更轻、排气更早、住院时间更短,90天死亡率与ODG相似。
  • 两组淋巴结清扫总数相似(LDG 46.6枚 vs ODG 47.4枚,P=0.451)。

核心结论

  • 对于局部进展期胃癌,腹腔镜远端胃切除术联合D2淋巴结清扫相比开腹手术并发症更少、恢复更快、疼痛更轻。

研究设计与样本

  • 多中心随机对照试验(KLASS-02-RCT),纳入组织学确诊的cT2-4a、N0-1期胃腺癌患者,2011年11月至2015年4月随机分配1050例至LDG组(n=526)或ODG组(n=524),实际治疗分析1011例。

主要发现

  • LDG组早期并发症发生率为16.6%,显著低于ODG组的24.1%(P=0.003)。
  • LDG组术后镇痛药使用和患者报告的疼痛评分显著低于ODG组。
  • LDG组首次排气时间更早(3.5 vs 3.7天,P=0.025),术后住院时间更短(8.1 vs 9.3天,P=0.005)。
  • 两组淋巴结清扫总数相似(LDG 46.6枚 vs ODG 47.4枚,P=0.451)。
  • 90天死亡率两组相似(LDG 0.4% vs ODG 0.6%,P=0.682)。

临床怎么用

  • 在具备腹腔镜技术条件的中心,对cT2-4a、N0-1期局部进展期胃癌可考虑采用腹腔镜远端胃切除联合D2淋巴结清扫以降低并发症、加速康复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of the study was to evaluate the short-term outcomes of KLASS-02-RCT, a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy (LDG) with D2 lymphadenectomy with open distal gastrectomy (ODG). SUMMARY BACKGROUND DATA: Although several benefits of laparoscopic gastric cancer surgery have been reported, strong evidence is still limited, especially in locally advanced gastric cancer which requires extensive lymph node dissection. METHODS: Enrollment criteria included histologically confirmed cT2-4a and N0-1 gastric adenocarcinoma. Thirty-day morbidity, 90-day mortality, postoperative pain, and recovery were compared between LDG and ODG groups. RESULTS: A total of 1050 patients were randomly assigned to LDG (n = 526) or ODG group (n = 524) between November 2011 and April 2015. After excluding patients who received bypass or no surgery, 1011 patients were analyzed as actual treatment group. Mean number of totally retrieved lymph nodes was similar in both groups (LDG = 46.6 vs ODG = 47.4, P = 0.451). Early morbidity rate was significantly lower after LDG (16.6%) than after ODG (24.1%; P = 0.003). Postoperative analgesics use and patients' reported pain score were significantly lower after LDG. First day of flatus was earlier after LDG (3.5 vs 3.7 d, P = 0.025) and postoperative hospital stay was shorter in LDG group (8.1 vs 9.3 d, P = 0.005). Ninety days' mortality rate was similar in both groups (LDG = 0.4% vs ODG = 0.6%, P = 0.682). CONCLUSIONS: Laparoscopic distal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer shows benefits in terms of lower complication rate, faster recovery, and less pain compared with open surgery.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Lee HJ, Hyung WJ, Yang HK, et al. Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT). Ann Surg. 2019. PMID: 30829698. doi:10.1097/SLA.0000000000003217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。